Evaluation of Ambulatory ECG Telemetry for the Early Detection of Atrial Fibrillation During Hospital Assessment of Cerebral Infarction

Not Applicable

Terminated

• Conditions: Cerebral Infarction
• Interventions: Device: ECG telemetry

• Registration Number: NCT03992157
• Lead Sponsor: Hopital Foch

Brief Summary

The aim of the study is to show that an ambulatory ECG telemetry monitoring of some patients hospitalized for cerebral infarction increases the frequency of the diagnosis of atrial fibrillation, cause of their stroke, and reinforces the protection against recurrences.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-12-27
• Study First Submitted: 2019-06-18
• Study First Submitted QC: 2019-06-18
• Study First Posted: 2019-06-20
• Primary Completion: 2019-07-03
• Study Completion: 2019-07-03
• Status Verified: 2019-12
• Last Update Submitted: 2019-12-30
• Last Update Posted: 2020-01-02

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 8

Inclusion Criteria

• Patients over 18 years old
• Diagnosis of transient ischemic or cerebral accident
• Absence of etiological orientation after the initial assessment (including at least cerebral MRI, angiography of the supra aortic trunks by CT or MRI, echocardiography with search for patent foramen ovale, standard biology)
• Affiliated to a social security system.
• Having given no opposition to participation in research

Read More

Exclusion Criteria

• AF known or diagnosed during stay in USINV

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
holter-ECG	ECG telemetry	Implementation of an ECG Holter during hospitalisation patient.

Primary Outcome Measures

Name	Time	Method
Diagnostic impact of outpatient ECG telemetry	6 months	Percentage of patients hospitalized for cerebral infarction and with a diagnosis of atrial fibrillation allowed by the use of ambulatory ECG telemetry.

Secondary Outcome Measures

Name	Time	Method
Evaluate the benefit on the recurrence rate of cerebral infarction after the exit of the service	3 months	Percentage of IC recurrence in the department and within 3 months of the IC diagnosis
Evaluate the therapeutic impact (prescription anticoagulant) at the end of hospitalisation	6 months	Percentage of patients on anticoagulation at the end of hospitalisation
Identification of prognostic factors to identify de novo atrial fibrillation	6 months	Retrospective evaluation of prognostic criteria (clinical data, biomarkers, abdominal MRI) in patients with a diagnosis of AF

Trial Locations

Locations (1)

Hopital Foch; 🇫🇷 Suresnes, France